CapForce IBD Breakout Opportunities ETF (BOUT) Stock Price, Quote, News & History

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Sector

Healthcare

Region

AUM

15.05M

Fund Score

Key Statistics

Open

High

52 Wk High

$49.41

AUM

15.05M

Dividend

$0.12

Ex-Div Date

Dec 31, 2025

Volume

Market Cap

$37.52B

Mgmt Fee

0.7%

P/E Ratio

20.26

Prev. Close

$42.94

Low

52 Wk Low

$35.05

Shares Out

400.00K

Yield

0.29%

Div. Freq

Avg. Volume Daily

2.34K

Beta

1.02

Avg. Expense Ratio

0.80%

P/B Ratio

3.84

Recent Capforce IBD Breakout Opportunities ETF News

Smart Beta Meets IBD: CapForce Rebrands Innovator's IBD Funds In Rules-Based Push

CapForce takes over FFTY and BOUT ETFs, rebranding IBD-based strategies, ssignaling a push to grow its rules-based ETF lineup.

Chandrima Sanyal

Amentum Secures Key Role In UK's First Small Modular Reactor Program

Amentum stock rises after securing a $406 million UK SMR contract, with technical signals and analyst outlook in focus.

Akanksha Bakshi

Amer Sports Crushes Q1 Estimates, Thanks To Arc'teryx And Salomon, Expects Tariff Impact To Be Negligible

Amer Sports, Inc. (NYSE:AS) shares rise premarket after reporting record first-quarter FY25 results with a 23% revenue increase and raised guidance for EPS and sales for FY25. CEO James Zheng states confidence in managing potential tariff outcomes. CFO Andrew Page expects minimal impact from current tariffs on 2025 financials.

Lekha Gupta

GEO Missed Q1 Targets On Rising Costs And Debt, Guides Q2 Below Street Estimates

GEO Group reported lower Q1 revenue and adjusted EBITDA, missing consensus. EPS also fell short. Outlook raised for FY25 but Q2 expectations lowered.

Lekha Gupta

Genpact Teams Up With Amazon Web Services To Accelerate AI Adoption Across Industries

Genpact and Amazon have a new strategic collaboration to accelerate AI adoption and drive business value across industries.

Lekha Gupta

FAQ

How do I buy CapForce IBD Breakout Opportunities ETF (BOUT) stock?

You can purchase shares of CapForce IBD Breakout Opportunities ETF (ARCA:BOUT) through any online brokerage.

View our list of the best stock brokerages

Who are CapForce IBD Breakout Opportunities ETF (BOUT) competitors?

There are no as such competitors for CapForce IBD Breakout Opportunities ETF.

What is the forecast, or price target, for CapForce IBD Breakout Opportunities ETF (BOUT) stock?

There is no analysis for CapForce IBD Breakout Opportunities ETF to provide a consensus price target.

What is the current price for CapForce IBD Breakout Opportunities ETF (BOUT)?

The stock price for CapForce IBD Breakout Opportunities ETF (ARCA: BOUT) is $43.384 last updated September 17, 2026 at 8:00 PM EDT.

Does CapForce IBD Breakout Opportunities ETF (BOUT) pay a dividend?

There are no upcoming dividends for CapForce IBD Breakout Opportunities ETF.

When is CapForce IBD Breakout Opportunities ETF (ARCA:BOUT) reporting earnings?

CapForce IBD Breakout Opportunities ETF does not have any upcoming earnings scheduled.

Is CapForce IBD Breakout Opportunities ETF (BOUT) going to split?

There is no upcoming split for CapForce IBD Breakout Opportunities ETF.

Key Statistics

Open

High

52 Wk High

$49.41

AUM

15.05M

Dividend

$0.12

Ex-Div Date

Dec 31, 2025

Volume

Market Cap

$37.52B

Mgmt Fee

0.7%

P/E Ratio

20.26

Prev. Close

$42.94

Low

52 Wk Low

$35.05

Shares Out

400.00K

Yield

0.29%

Div. Freq

Avg. Volume Daily

2.34K

Beta

1.02

Avg. Expense Ratio

0.80%

P/B Ratio

3.84

About

Sector

N/A

Industry

N/A

ETF Details

Sector	Healthcare
Category	Mid Performer-Mid Growth
Investment Style	Mid Cap Growth
Fund Inception	Sep 12, 2018
Managers	Christine Johanson Ernesto Tong Dustin Lewellyn
Definition	Most of the stocks in this equity fund have average financial performance and average growth potential

Investment Policy

The fund will normally invest at least 80% of its net assets (including investment borrowings) in the equity securities that comprise the index. The index seeks to provide opportunistic investment exposure to those stocks with the potential to break out, or experience a period of sustained price growth beyond the stocks recent resistance level, with consideration for various market conditions. The fund is non-diversified.

Top ETF Holdings

Symbol	Name	Share %
ELVN	Enliven Therapeutics I...	6.78%
TGTX	Tg Therapeutics Inc	7.01%
HNGE	Hinge Health Inc	7.33%
TVTX	Travere Therapeutics I...	7.06%
LU	Ternium Sa	6.92%
NESR	National Energy Servic...	6.38%
SM	Ubs Group Ag	6.28%
BAC	Bank Of America Corp	6.03%
EMR	Emerson Electric Co.	5.82%
BV	Embraer S.A. Sponsored...	5.66%